Literature DB >> 22227512

Fistula formation between the right and left main bronchus caused by endobronchial tuberculosis.

Alireza Nemati1, Enayat Safavi, Mehrnaz GhasemiEsfe, Mohammadreza Zahedpour Anaraki, Shahram Firoozbakhsh, Omid Khalilzadeh, Mehdi Anvari.   

Abstract

The prevalence of endobronchial tuberculosis (EBTB) in patients with active tuberculosis is about 10% to 40%. The most common complication of EBTB is bronchial stenosis. Fistula formation by pulmonary tuberculosis is a very rare complication and is most commonly bronchopleural. The authors present a 53-year-old woman presented with chronic cough and abnormality in chest computed tomography scan. According to chest computed tomography scan finding, bronchoscopic study was done and bronchial lavage was obtained. Bronchial lavage was positive for acid fast bacilli. Bronchoscopy showed fistula formation between the right and left main bronchus, a rare manifestation of EBTB. The patient was treated with antituberculosis therapy, and her symptoms improved and radiological findings showed regression of pulmonary lesions.

Entities:  

Mesh:

Year:  2012        PMID: 22227512     DOI: 10.1097/MAJ.0b013e31823e612a

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  Unusual clinical presentation of thoracic tuberculosis: the need for a better knowledge of illness.

Authors:  Sandra Manca; Alessandro Giuseppe Fois; Luigi Santoru; Rocco Trisolini; Maria Francesca Polo; Salvatore Ostera; Marco Patelli; Pietro Pirina
Journal:  Am J Case Rep       Date:  2015-04-24

2.  Multislice computed tomography and virtual bronchoscopy diagnosis of interbronchial fistula.

Authors:  Venkatraman Indiran
Journal:  Lung India       Date:  2017 Jan-Feb

3.  Proteomic profiling of biomarkers by MALDI-TOF mass spectrometry for the diagnosis of tracheobronchial stenosis after tracheobronchial tuberculosis.

Authors:  Bihao Peng; Xiaojian Qiu; Zhiwu Dong; Jie Zhang; Yinghua Pei; Ting Wang
Journal:  Exp Ther Med       Date:  2020-11-19       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.